From May 11 to 15, 2025, Trasis will be present at the 26th International Symposium on Radiopharmaceutical Sciences (iSRS) on Australia’s Gold Coast.

At Trasis, we’re committed to leading the way in developing automated solutions and dedicated synthesis sets, including the development and manufacturing of APIs, for the next generation of diagnostic and therapeutic radiopharmaceuticals.

Our highlights at ISRS 2025

Automated synthesis platforms adapted to a wide range of isotopes and chemistries, including [¹⁸F], [⁶⁸Ga], [¹⁷⁷Lu], and beyond.
Universal cassettes and reagent kits, including those for [¹⁸F]NOTA-peptide and novel theranostic compounds.
End-to-end CDMO services, from early-stage development through to GMP production.
QC1, our compact and comprehensive quality control instrument, streamlining batch release while minimizing operator exposure.

Let’s talk science and solutions

Join our team at Booths 1 & 20 and attend the Trasis User Meeting on May 11 at Sofitel Gold Coast Broadbeach. We’ll share the latest developments in radiopharmaceutical technology and open the floor to discussion.

Related contents

Trasis Innovation Newsletter - March 2025

2024: a record-breaking year for Trasis